Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic microflora refers to the collective group of microorganisms, including bacteria, fungi, viruses, and parasites, that are capable of causing infectious diseases in a host organism [1]. This term is not a single molecular target like an enzyme or receptor; rather, it represents a diverse biological category of entities that disrupt host homeostasis through mechanisms such as toxin production, tissue invasion, and immune evasion [2]. In clinical pharmacology, drugs are designed to target specific molecular components within these organisms—such as the bacterial ribosome, cell wall synthesis enzymes, or fungal ergosterol—to inhibit growth or induce cell death [3]. A major challenge in addressing pathogenic microflora is the emergence of antimicrobial resistance (AMR), which renders standard treatments ineffective [4]. Furthermore, broad-spectrum therapeutic interventions often result in dysbiosis, the harmful disruption of the host's commensal microbiome [5]. References: [1] National Institute of Allergy and Infectious Diseases (NIAID); [2] StatPearls, 'Infection Control'; [3] Merck Manuals, 'Overview of Antibacterial Drugs'; [4] World Health Organization (WHO), 'Antimicrobial Resistance'; [5] Nature Reviews Microbiology, 'The Human Microbiome and Infectious Diseases'.
Inhibition of cell wall synthesis, inhibition of protein synthesis (ribosomal targeting), inhibition of nucleic acid synthesis, disruption of cell membrane integrity, and inhibition of essential metabolic pathways.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic microflora.